Blood

Bio & Pharma ABL Bio lands $2.8 billion license-out deal with GSK

ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...

Korean Investors Samsung to invest $10 million in US-based C2N Diagnostics

Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...

Bio & Pharma GC Biopharma acquires ABO Holding for $96 mn

South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...

Bio & Pharma Celltrion's anti cancer drugs hold 90% market share in C.America

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Korean startups Near Brain gives hope to millions of stroke patients worldwide

Strokes are the second leading cause of death and the third leading cause of disabilities globally, according to the World Health Organization.To fi...

Bio & Pharma GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...

Bio & Pharma GC Biopharma exports Alyglo to US

South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...

Bio & Pharma Bio startup ArtBlood attracts $4.8 mn investment

South Korean bio startup ArtBlood, specializing in blood production for transfusion, announced on Tuesday that it successfully secured an investment...

Bio & Pharma Kakao launches AI-based blood sugar management solution

South Korea’s Kakao Healthcare Corp. has introduced an artificial intelligence-based blood sugar management solution targeting the global digi...

Bio & Pharma GC Biopharma gets FDA approval for Alyglo

South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...

Bio & Pharma GC Biopharma breaks ground on blood product plant in Indonesia

South Korea’s GC Biopharma Corp. broke ground on Wednesday on Indonesia’s first blood product plant through technology transfer.Indonesi...

Bio & Pharma Curocell to localize blood cancer drug by 2025

South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...

Bio & Pharma SK Plasma gets investment from Indonesian fund

South Korea’s SK Plasma on Tuesday said it signed a term sheet, or a nonbinding agreement on the basic terms and conditions of an investment, ...

Bio & Pharma NGeneBio applies for US patent of early diagnosis tech of dementia

South Korean medical diagnostic company NGeneBio Co. announced on Thursday that it has completed the US patent application for its technology relate...

Bio & Pharma S.Korea's Boryung gets gov’t OK for diabetes drug Trubuddy

South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...

Bio & Pharma Ildong Pharma to export high blood pressure treatment to China

South Korea's Ildong Pharmaceutical Co. on Tuesday said it will export benidipine hydrochloride, a raw material used in the treatment of high blood ...

Bio & Pharma Kakao Healthcare signs agreement with Novo Nordisk for digital service

Kakao Healthcare Corp., a digital healthcare platform unit of South Korea's Kakao Corp., announced that it has signed on Tuesday a business agreemen...

Bio & Pharma Clinomics releases equipment that quickly finds lung cancer mutations

Clinomics, a South Korean biotech company specializing in liquid biopsies, on Thursday said it developed equipment that can detect four types of l...

Bio & Pharma GC Biopharma inks $90mn deal for blood products in Brazil

South Korea's GC Biopharma Corp. on Monday announced on Monday that it has a supply contract with Blau Farmacêutica, a Brazilian pharmaceutica...

Bio & Pharma SK Plasma to supply $30 mn in blood products to Singapore

South Korea's SK Plasma on Wednesday announced the launch of full-scale production this month of the blood products albumin and immunoglobulin for S...

Bio & Pharma S.Korea's ToolGen develops gene-edited cow for artificial blood

South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...

Bio & Pharma GC Biopharma wins contract to build blood products plant in Indonesia

GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Healt...

Bio & Pharma Samsung Bioepis gets approval to sell biosimilar in Europe

South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...

Food & Beverage Kolmar BNH gets approval for health functional food ingredient in US

Kolmar BNH Co. has received approval from the US Food and Drug Administration (FDA) for a domestically developed health functional food ingredient.K...

Bio & Pharma LG Chem to launch new diabetes combination drug Zemidapa

South Korean chemical company LG Chem Ltd. has announced the release of a new diabetes combination drug, Zemidapa Tab, set to launch on Apr. 8. Th...

Bio & Pharma Medical IP's X-ray image analysis software certified as medical device

Medical IP, a South Korean medical AI company, has announced that its artificial intelligence (AI) medical image analysis software "TiSepX Lung Volu...

Bio & Pharma SK Plasma to build blood products plant in Indonesia

South Korea’s SK Plasma will build a blood products plant in Indonesia.Industry sources on Tuesday said the company recently received approval...

Bio & Pharma GC Biopharma introduces candidates for treating blood coagulation disease

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

Bio & Pharma JW Pharma applies for phase 3 trial in Taiwan for gout treatment

JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...

Bio & Pharma S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer

South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...